Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumorRecruitingPhase 32026-02-11NCT06937905

1 results · Page 1 of 1

Swipe the table sideways for more columns.

37 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Angers - CHUAngersFrance9
Avignon - CHAvignonFrance6
Besançon - CHUBesançonFrance7
Bordeaux - CHUPessacFrance7
Boulogne - Ambroise ParéBoulogneFrance3
Caen - CHUCaenFrance6
Dijon - Centre Georges-François LeclercDijonFrance2
Dijon - CHU BocageDijonFrance4
Grenoble - CHUGrenobleFrance7
Le Mans - CHGLe MansFrance10
Lille - Centre Oscar LambretLilleFrance1
Limoges - CHULimogesFrance2
Lyon - Centre Léon BérardLyonFrance4
Lyon - HCLPierre-BéniteFrance4
Lyon - Hôpital Edouard HerriotLyonFrance1
Lyon - Hôpital Privé Jean MermozLyonFrance1
Marseille - APHMMarseilleFrance6
Marseille - Institut Paoli-CalmettesMarseilleFrance1
Montpellier - CHUMontpellierFrance6
Nantes - Hôpital LaennecSaint-HerblainFrance1
Nantes - Institut de Cancérologie de l'OuestSaint-HerblainFrance1
Nice - Centre Antoine LacassagneNiceFrance1
Paris - CurieParisFrance2
Paris - Hôpital CochinParisFrance5
Paris - Saint-AntoineParisFrance1